Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $216.00
Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its target price raised by Mizuho from $212.00 to $216.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock. Other analysts have also issued reports about the company. Royal Bank of Canada lifted their price objective on Axsome […]
More Stories
Over Arizona’s Red Rock Country, Balloons Take to the Skies
By Allan Stein PAGE, Ariz.—Scattered cheers rang out across the golf course as a small red test balloon drifted into...
Trump Orders DOJ to Probe Alleged Threats by Democrats Against Conservatives
By Tom Gantert President Donald Trump said he’s ordering the Justice Department to investigate Democratic political leaders he says have...
OpenAI Pledges to Cover Data Centers’ Full Energy Costs
By Bill Pan OpenAI said it will pay the full energy costs of future data centers it owns and operates,...
Amid Calls for a Nationwide Wealth Tax, Critics Warn of Lost Investment and Jobs
By Kevin Stocklin Although California voters rejected the state’s proposed “billionaire’s tax” at the midterm ballot box, politicians and groups...
Israeli President Hands Opposition Candidate First Chance at Forming Government
By Melanie Sun Israeli President Isaac Herzog on Saturday night said he would hand opposition leader Gadi Eisenkot the first...
Trump Offers White House Press Secretary Job to UFC Chief Dana White
By Sylvia Xu President Donald Trump said on Saturday that he offered the White House press secretary job to Ultimate...